Do potential patients prefer tissue plasminogen activator (TPA) over streptokinase (SK)?: An evaluation of the risks and benefits of TPA from the patient's perspective
Daren K Heyland, Amiram Gafni, Mitchell A.H LevineVolume:
53
Year:
2000
Language:
english
DOI:
10.1016/s0895-4356(99)00214-0
File:
PDF, 196 KB
english, 2000